The Zhitong Finance App learned that Hygea Healthcare (06078) continued to rise, reaching a new high of HK$11.18 since May this year. As of press release, it rose 5.73% to HK$11.08, with a turnover of approximately HK$31.0287 million.
According to the news, in June of this year, Hygea announced that it will use about 500 million yuan per year for share repurchases and/or dividends for the next three fiscal years. According to reports, as of October 31, the company had repurchased a total of 16.686 million shares, accounting for about 5.1% of the share capital of non-controlling shareholders (total share capital - shares held by controlling shareholders). Depending on market conditions, such repurchased shares will be cancelled in accordance with listing rules and applicable laws and regulations.
In the first half of this year, Hygea Healthcare achieved revenue of 1.96 billion yuan, a year-on-year decrease of 1.4%; net profit of 260 million yuan, an increase of 4.7% year-on-year. Despite a slight year-on-year decline in revenue, the core operating indicators maintained steady growth. The number of patients treated the company reached 2.3 million in the first half of the year, an increase of 4.1%; the number of completed surgeries was about 46,000, an increase of 8.2% over the previous year. Among them, the number of level 3 and 4 surgeries representing core technical capabilities was about 21,000, an increase of 17.8% over the previous year, and the growth rate was significantly higher than the overall number of surgeries.